Crack cocaine never disappeared. While use has dropped dramatically from the peak of the 1980s epidemic, crack remains actively manufactured, sold, and consumed across the United States. Federal forensic labs still analyze tens of thousands of cocaine samples each year in both powder and rock form, and crack trafficking cases continue to move through federal courts in significant numbers. What has changed is the scale, the demographics, the purity of the supply, and the new danger of fentanyl contamination.
How Use Compares to the 1980s Peak
The crack epidemic of the mid-1980s was a public health catastrophe that reshaped American cities, policing, and sentencing laws. At its height, crack use was spreading rapidly across income levels and age groups. That wave broke hard. Use among young people dropped sharply from 1986 through 1991, ticked back up during a secondary wave in the late 1990s, and has been declining since.
By 2023, past-year crack use among 8th, 10th, and 12th graders had fallen to 0.5% or less, near historic lows according to the Monitoring the Future survey, which has tracked youth drug use since the 1970s. Crack is no longer the cultural force it once was, but “near historic lows” is not the same as zero. The drug persists in specific communities and markets, particularly in the urban Northeast and parts of the Southeast. The top five federal districts for crack trafficking cases in 2024 were the Southern District of New York, the District of New Jersey, Western Pennsylvania, Eastern North Carolina, and Eastern New York.
Who Is Still Using Crack
The profile of people caught up in crack today looks different from the popular image of the 1980s epidemic, though some patterns persist. Among individuals sentenced for federal crack trafficking offenses in fiscal year 2024, the average age was 39, and nearly 92% were men. The racial disparity remains stark: 77.1% of those sentenced were Black, 14.9% Hispanic, and 7.3% White. Almost all (98.1%) were U.S. citizens.
These numbers reflect who gets prosecuted in the federal system, which is not a perfect mirror of who actually uses or sells crack. But they highlight a reality that has persisted for decades: crack enforcement continues to fall disproportionately on Black communities, a pattern that has fueled ongoing debates about sentencing fairness.
The Sentencing Gap Still Exists
For years, federal law punished crack offenses far more harshly than equivalent powder cocaine offenses, originally at a 100-to-1 ratio. That meant possessing 5 grams of crack triggered the same mandatory minimum sentence as 500 grams of powder cocaine, despite being chemically similar substances. The Fair Sentencing Act of 2010 narrowed that ratio to roughly 18-to-1, but it did not eliminate the gap.
Legislation to close the remaining disparity has been introduced repeatedly. The SMART Cocaine Sentencing Act, introduced in the Senate in 2023, proposed raising the crack threshold from 28 grams to 160 grams while lowering the powder threshold from 500 to 400 grams. As of the end of the 118th Congress, the bill had not advanced past committee. The sentencing disparity remains federal law.
Today’s Supply Is Purer and More Dangerous
One thing that has changed significantly is purity. The average purity of cocaine samples (both powder and rock forms) analyzed by DEA labs in 2024 was 84%, with some batches testing at 88%, the highest level documented by federal testing programs in the past decade. Higher purity means a more potent product reaching users, which increases the risk of overdose and cardiovascular emergencies even for experienced users who think they know their tolerance.
The more alarming shift is fentanyl contamination. Roughly one in four cocaine samples submitted to federal forensic labs in 2024 contained fentanyl or fentanyl-related compounds. This is not always intentional on the part of dealers. Cross-contamination can happen when different drugs are processed on the same surfaces or with the same equipment. But the result is the same: someone smoking crack who has no opioid tolerance can receive a lethal dose of fentanyl without knowing it.
Cocaine-related overdose deaths rose steadily for eight consecutive years, with the vast majority involving synthetic opioids like fentanyl. The trend finally reversed in 2024, with provisional CDC data showing a 25% decline to roughly 22,678 cocaine-related deaths in the 12-month period ending October 2024. That’s still a massive number, roughly ten times the annual cocaine death toll from the height of the original crack epidemic.
What Crack Does to the Body
Crack delivers cocaine to the brain in seconds through the lungs, producing a short, intense high that powder cocaine snorted through the nose cannot match. That rapid delivery is what makes crack so addictive, but it also concentrates the drug’s physical damage.
The cardiovascular effects are severe. Cocaine forces the heart to work harder by raising heart rate and blood pressure, increasing the heart’s demand for oxygen. At the same time, it constricts the blood vessels supplying the heart, cutting oxygen delivery. This mismatch can trigger a heart attack even in young, otherwise healthy people. Over time, repeated use thickens the heart muscle, weakens its pumping ability, and promotes the buildup of calcium and inflammatory plaques inside coronary arteries. The drug also makes blood more likely to clot, compounding the risk.
Heart rhythm disturbances are common. Cocaine interferes with the electrical signals that coordinate heartbeats, which can cause dangerous irregular rhythms. These effects occur both during active use and in the hours afterward, when the drug is still clearing the body.
Stroke risk roughly doubles with cocaine use, for both the type caused by a blocked blood vessel and the type caused by bleeding in the brain. Long-term users also face progressive damage to the lungs (sometimes called “crack lung”), nasal and oral tissue destruction, and cognitive decline from repeated disruption of normal brain chemistry.
Treatment Options for Crack Addiction
There is no FDA-approved medication specifically for cocaine or crack addiction, which makes treatment harder than for opioid or alcohol dependence. The most effective approach supported by research is contingency management, a behavioral therapy that provides tangible rewards (gift cards, vouchers, or small cash incentives) for clean drug tests. Meta-analyses consistently find it outperforms other approaches for keeping people in treatment and achieving sustained abstinence.
Contingency management works because crack addiction is driven by the brain’s reward system, and offering an alternative, immediate reward can compete with the pull of the drug. Cognitive behavioral therapy is often used alongside it, helping people identify triggers and build coping strategies. Treatment programs that combine both tend to produce better outcomes than either alone. Recovery is possible, but relapse rates are high, and most people need multiple treatment attempts before achieving long-term sobriety.
Why Crack Persists
Crack remains “a thing” for a simple reason: it delivers an extremely intense, extremely cheap high. A single hit can cost as little as a few dollars, making it accessible in a way that powder cocaine, often associated with higher-income users, is not. The cocaine supply chain from South America remains robust, and as long as powder cocaine flows into the country, some of it will be converted to crack in domestic kitchens and stash houses. The drug’s cultural visibility has faded since the 1980s, but in the communities where it persists, the human toll remains real.